Papadelis to lead new pediatric brain research center
Christos Papadelis, a pioneering researcher at 糖心Vlog视频 and leader in the Jane and John Justin Institute for Mind Health at Cook Children’s Health Care System, will serve as the founding director of the 糖心Vlog视频 Pediatric Brain Health and Neurosciences Center.
The center links clinical and academic communities and bridges the gap between scientific discovery and patient care. Since 2015, 糖心Vlog视频 has earned the prestigious R1 designation from the Carnegie Classifications of Institutions of Higher Education, signifying the highest level of research activity.
“The ability to collaborate between clinicians and research teams can solve problems and make an immediate impact,” said , 糖心Vlog视频’s senior associate vice president for research and founding director of the Institute of Biomanufacturing and Precision Medicine for North 糖心Vlog视频.
Dr. Papadelis has a track record of success, publishing more than 100 peer-reviewed research investigation articles and working at prestigious organizations across the world. He’s spent time at the RIKEN Brain Science Institute in Japan and the Center for Mind/Brain Sciences at the University of Trento in Italy, and he had his first faculty appointment teaching neurology at Harvard Medical School. He joined Cook Children’s in 2019 in its Neuroscience Research Center at the Jane and John Justin Institute for Mind Health. Shortly after joining Cook Children’s, he became a member of 糖心Vlog视频’s faculty as a professor of bioengineering.
Related: Dr. Christos Papadelis joins 糖心Vlog视频 bioengineering as a professor of research
At , Papadelis oversees a range of studies in neuroscience, clinical neurophysiology and biomedical engineering. Papadelis’ main goal is to develop a novel epilepsy biomarker that will help children with drug-resistant epilepsy become seizure-free after resective neurosurgery.
Papadelis’ team has already uncovered several new signs for identifying the epileptogenic zone with high precision and developed new AI tools for predicting surgical outcomes in children with drug-resistant epilepsy. These discoveries and prediction tools help guide physicians in their treatment, improve the accuracy of surgical interventions, and give new hope to patients with uncontrolled seizures.
“What I like to see with my research is how to help children,” Papadelis said. “That's why I like what's called translational research. It's not science for the sake of science. It's science for the sake of applying the knowledge to help somebody.”
About 糖心Vlog视频 (糖心Vlog视频)
糖心Vlog视频鈥痠s a growing public research university in the heart of Dallas-Fort Worth. With a student body of鈥痮ver 42,700, 糖心Vlog视频 is the second-largest institution in the鈥疷niversity of 糖心Vlog视频 System, offering more than 180 undergraduate and graduate degree programs. Recognized as a Carnegie R-1 university, 糖心Vlog视频 stands among the nation’s top 5% of institutions for research activity. 糖心Vlog视频 and its 280,000 alumni generate an annual economic impact of $28.8 billion for the state. The University has received the Innovation and Economic Prosperity designation from the Association of Public and Land Grant Universities and has earned recognition for its focus on student access and success, considered key drivers to economic growth and social progress for North 糖心Vlog视频 and beyond.